Feb 26, 2018
Jodi Avergun, chair of the firm’s White Collar Defense and Investigations practice, was quoted in The Washington Post on Feb. 26 in a story titled “The Health 202: States are going after opioid makers.”
Avergun, who served as chief of staff of the U.S. Drug Enforcement Administration and is a former federal prosecutor, explained the difference between lawsuits over the opioid crisis and the tobacco industry litigation in the 1990s.
“Did the manufacturers understate the addictive nature of the drugs?” she said. “That’s entirely possible, but to say everything that ensued from that point on is the fiscal responsibility of the manufacturer I think is a very questionable proposition.”
The Bank of England has initiated a review of its own exposure to LIBOR,
Scott Cammarn, Jonathan Watkins, Mark Chorazak, Aaron Lang
On 7 June 2019, Regulation (EU) 2019/876 (CRR II) was published in the Official Journal of the EU.